Cargando…
Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19
Before the COVID-19 pandemic, many pregnant patients experienced barriers in accessing opioid use disorder (OUD) medication. This project surveyed buprenorphine treatment clinics to determine how many accepted pregnant women before and then during the pandemic. Of those clinics accepting pregnant pa...
Autores principales: | Lensch, Ashley C., Hairston, Essence, Carter, Ginny, Jones, Hendrée E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368085/ https://www.ncbi.nlm.nih.gov/pubmed/33606424 http://dx.doi.org/10.1097/ADM.0000000000000826 |
Ejemplares similares
-
Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period
por: Jones, Hendrée E., et al.
Publicado: (2021) -
Concurrent Opioid and Alcohol Use Among Women Who Become Pregnant:
Historical, Current, and Future Perspectives
por: Klaman, Stacey L, et al.
Publicado: (2019) -
Shared Decision‐Making Tool for Treatment of Perinatal Opioid Use Disorder
por: Guille, Constance, et al.
Publicado: (2019) -
Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta‐analysis of safety in the mother, fetus and child
por: Zedler, Barbara K., et al.
Publicado: (2016) -
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance
por: Klaman, Stacey L., et al.
Publicado: (2017)